Microbiome Isolation and DNA Enrichment Protocol: Pathogen Detection Webinar ...QIAGEN
This slidedeck presents an easy-to-use workflow that allows selective isolation of microbial DNA from samples that are intrinsically rich in host DNA. This protocol includes steps for efficient depletion of host DNA while providing optimized conditions specific for bacterial lysis. This workflow is also specific for the identification of live bacteria, avoiding false results due to nucleic acids from dead bacteria. Enriched microbial DNA can be directly used in other molecular methods such as whole genome sequencing, qPCR and microarray assays.
The Microbiome: Sorting the Hype from the Hope DrBonnie360
Content and Visual Design by Tiffany Simms
Cambridge Healthtech Institute's 23rd International Molecular-Med Tri-Con presents a short course on the Microbiome.
DrBonnie360 brings together two rising stars of the Sonnenburg Lab and the Knight Lab, and four microbiome companies, Second Genome, Osel Inc, AOBiome, and WholeBiome, to discuss the importance of the microbiome and how we can harness its power.
The course took place Sunday, March 6, 2016 in San Francisco.
Clinical Metagenomics for Rapid Detection of Enteric Pathogens and Characteri...QIAGEN
High-throughput sequencing, combined with high-resolution metagenomic analysis, provides a powerful diagnostic tool for clinical management of enteric disease. Forty-five patient samples of known and unknown disease etiology and 20 samples from health individuals were subjected to next-generation sequencing. Subsequent metagenomic analysis identified all microorganisms (bacteria, viruses, fungi and parasites) in the samples, including the expected pathogens in the samples of known etiology. Multiple pathogens were detected in the individual samples, providing evidence for polymicrobial infection. Patients were clearly differentiated from healthy individuals based on microorganism abundance and diversity. The speed, accuracy and actionable features of CosmosID bioinformatics and curated GenBook® databases, implemented in the QIAGEN Microbial Genomics Pro Suite, and the functional analysis, leveraging the QIAGEN functional metagenomics workflow, provide a powerful tool contributing to the revolution in clinical diagnostics, prophylactics and therapeutics that is now in progress globally.
Microbiome Diagnostics Platform for Microbiome Health and Colon Cancer Preven...Laura Berry
Presented at the 4th Microbiome R&D and Business Collaboration Forum: USA. To find out more, visit: www.global-engage.com
Greg Kuehn, President and COO of Metabiomics, presents the MB-01 colorectal adenoma clinical research study, sequencing technology and microbiome diagnostics platform.
Microbiome Isolation and DNA Enrichment Protocol: Pathogen Detection Webinar ...QIAGEN
This slidedeck presents an easy-to-use workflow that allows selective isolation of microbial DNA from samples that are intrinsically rich in host DNA. This protocol includes steps for efficient depletion of host DNA while providing optimized conditions specific for bacterial lysis. This workflow is also specific for the identification of live bacteria, avoiding false results due to nucleic acids from dead bacteria. Enriched microbial DNA can be directly used in other molecular methods such as whole genome sequencing, qPCR and microarray assays.
The Microbiome: Sorting the Hype from the Hope DrBonnie360
Content and Visual Design by Tiffany Simms
Cambridge Healthtech Institute's 23rd International Molecular-Med Tri-Con presents a short course on the Microbiome.
DrBonnie360 brings together two rising stars of the Sonnenburg Lab and the Knight Lab, and four microbiome companies, Second Genome, Osel Inc, AOBiome, and WholeBiome, to discuss the importance of the microbiome and how we can harness its power.
The course took place Sunday, March 6, 2016 in San Francisco.
Clinical Metagenomics for Rapid Detection of Enteric Pathogens and Characteri...QIAGEN
High-throughput sequencing, combined with high-resolution metagenomic analysis, provides a powerful diagnostic tool for clinical management of enteric disease. Forty-five patient samples of known and unknown disease etiology and 20 samples from health individuals were subjected to next-generation sequencing. Subsequent metagenomic analysis identified all microorganisms (bacteria, viruses, fungi and parasites) in the samples, including the expected pathogens in the samples of known etiology. Multiple pathogens were detected in the individual samples, providing evidence for polymicrobial infection. Patients were clearly differentiated from healthy individuals based on microorganism abundance and diversity. The speed, accuracy and actionable features of CosmosID bioinformatics and curated GenBook® databases, implemented in the QIAGEN Microbial Genomics Pro Suite, and the functional analysis, leveraging the QIAGEN functional metagenomics workflow, provide a powerful tool contributing to the revolution in clinical diagnostics, prophylactics and therapeutics that is now in progress globally.
Microbiome Diagnostics Platform for Microbiome Health and Colon Cancer Preven...Laura Berry
Presented at the 4th Microbiome R&D and Business Collaboration Forum: USA. To find out more, visit: www.global-engage.com
Greg Kuehn, President and COO of Metabiomics, presents the MB-01 colorectal adenoma clinical research study, sequencing technology and microbiome diagnostics platform.
This presentation include microbiome involve in human health and disease. classification and categorization of microbiota is aslo given.Anatomical area in which these microbes present.
Mapping the Human Gut Microbiome in Health and Disease Using Sequencing, Supe...Larry Smarr
Invited Talk Delivered by Mehrdad Yazdani, Calit2 Ayasdi Sponsored Lunch & Learn American Society of Human Genetics (ASHG) San Diego Convention Center October 19, 2014
The Human Microbiome in Sports Performance and Healthctorgan
Because our knowledge of the human microbiome is moving so rapidly, we turned our presentation at this conference into a discussion session so experts in the audience could share their professional knowledge and personal experience. By the end of the session, it was clear that we had barely scratched the surface of the importance of our microscopic kin to our health, to sports performance, and to how we need to think about designing research studies. A list of recommended resources is available at: www.caroltorgan.com/microbiome-sports/. We welcome your input!
Bridging the Autoimmune Abyss through New DiscoveriesDrBonnie360
A comprehensive collection of our autoimmunity research done in an effort to help bridge the gap for the large and growing needs of the autoimmune community. This bibliography is a sneak peak at an upcoming white paper for the lonely voices of autoimmune disease.
Topics Include:
Prevalence & Incidence
Immunology
Polyautoimmunity
Current Treatments & Therapies
The Microbiome
Data and Digital Tools
Causes of Autoimmune Disease
Prevention & Lifestyle Modification
The Human Microbiome Project (HMP) was a United States National Institutes of Health (NIH) research initiative to improve understanding of the microbial flora involved in human health and disease.
Exploring and Mapping Autoimmune Disease Using Data and Digital Tools - SourcesDrBonnie360
Exciting talk bringing Big Data and autoimmunity together at the Cambridge HealthTech Institute's Bio-IT World Conference and Expo. April 21-23, Boston.
Content and Visual Design by Tiffany Simms
Hervé Blottiere-El impacto de las ciencias ómicas en la medicina, la nutrició...Fundación Ramón Areces
El 29 de marzo de 2016 celebramos un Simposio Internacional sobre el 'Impacto de las ciencias ómicas en la medicina, nutrición y biotecnología'. Organizado por la Fundación Ramón Areces en colaboración con la Real Academia Nacional de Medicina y BioEuroLatina, abordó cómo un mejor conocimiento del genoma humano está permitiendo notables avances hacia una medicina de precisión.
Find out about collaboration and partnership opportunities with the Wellcome Sanger Institute that aims to create exceptional healthcare opportunities for everyone from extraordinary science.
This presentation include microbiome involve in human health and disease. classification and categorization of microbiota is aslo given.Anatomical area in which these microbes present.
Mapping the Human Gut Microbiome in Health and Disease Using Sequencing, Supe...Larry Smarr
Invited Talk Delivered by Mehrdad Yazdani, Calit2 Ayasdi Sponsored Lunch & Learn American Society of Human Genetics (ASHG) San Diego Convention Center October 19, 2014
The Human Microbiome in Sports Performance and Healthctorgan
Because our knowledge of the human microbiome is moving so rapidly, we turned our presentation at this conference into a discussion session so experts in the audience could share their professional knowledge and personal experience. By the end of the session, it was clear that we had barely scratched the surface of the importance of our microscopic kin to our health, to sports performance, and to how we need to think about designing research studies. A list of recommended resources is available at: www.caroltorgan.com/microbiome-sports/. We welcome your input!
Bridging the Autoimmune Abyss through New DiscoveriesDrBonnie360
A comprehensive collection of our autoimmunity research done in an effort to help bridge the gap for the large and growing needs of the autoimmune community. This bibliography is a sneak peak at an upcoming white paper for the lonely voices of autoimmune disease.
Topics Include:
Prevalence & Incidence
Immunology
Polyautoimmunity
Current Treatments & Therapies
The Microbiome
Data and Digital Tools
Causes of Autoimmune Disease
Prevention & Lifestyle Modification
The Human Microbiome Project (HMP) was a United States National Institutes of Health (NIH) research initiative to improve understanding of the microbial flora involved in human health and disease.
Exploring and Mapping Autoimmune Disease Using Data and Digital Tools - SourcesDrBonnie360
Exciting talk bringing Big Data and autoimmunity together at the Cambridge HealthTech Institute's Bio-IT World Conference and Expo. April 21-23, Boston.
Content and Visual Design by Tiffany Simms
Hervé Blottiere-El impacto de las ciencias ómicas en la medicina, la nutrició...Fundación Ramón Areces
El 29 de marzo de 2016 celebramos un Simposio Internacional sobre el 'Impacto de las ciencias ómicas en la medicina, nutrición y biotecnología'. Organizado por la Fundación Ramón Areces en colaboración con la Real Academia Nacional de Medicina y BioEuroLatina, abordó cómo un mejor conocimiento del genoma humano está permitiendo notables avances hacia una medicina de precisión.
Find out about collaboration and partnership opportunities with the Wellcome Sanger Institute that aims to create exceptional healthcare opportunities for everyone from extraordinary science.
Sample Prep Solutions for Microbiome ResearchQIAGEN
An accurate molecular analysis of the microbial constituents of a particular community is contingent upon high-yielding and non-biased nucleic acid extraction methodologies. Only by ensuring that all species and classes of microorganisms present in a sample are effectively lysed during extraction will one be able to reliably assess the composition of that sample. An additional challenge faced in nucleic acid extraction is the presence of persistent, co-purifying polymerase inhibitors endogenous to one’s sample. This presentation will focus on nucleic acid extraction tools developed by MO BIO Laboratories that facilitate accurate non-biased community analysis and eliminate common amplification problems via the depletion of endogenous polymerase inhibitors using our patented Inhibitor Removal Technology.
Medical Biotechnology and Genetics Journal - SciDocPublishersScidoc Publishers
International Journal of Medical Biotechnology & Genetics (IJMBG) ISSN: 2379-1020 is a comprehensive, peer reviewed journal devoted to Medical Biotechnology & Genetics. IJMBG, published by SciDocPublishers is an Open Access journal that includes high quality papers, which covers all major areas of Medical Biotechnology & Genetics. SciDocPublishers with its Open Access publication model spreads all the day-to-day developments and research to readers around the world.
IJMBG retains its interest in evolutionary research as an international journal dedicated to the latest advancement of Medical Biotechnology & Genetics. It provides a platform for Scientists and Academicians all over the world to promote, share, and discuss various new issues and developments in different areas of Medical Biotechnology & Genetics.
For more details: http://scidoc.org/medical-biotechnology-and-genetics.php
Applications of bioinformatics, main by kk sahuKAUSHAL SAHU
Introduction
Goals of Bioinformatics
Bioinformatics & Human Genome
Project
What can we do using bioinformatics ?
Applications of bioinformatics in various fields
1) Medicine
2) Evolutionary studies
3) Agriculture
4) Microbiology
5) Biotechnology
Conclusion
References
Similar to Era7 bioinformatics and_the_microbiome_november_2016 (20)
Multi-source connectivity as the driver of solar wind variability in the heli...Sérgio Sacani
The ambient solar wind that flls the heliosphere originates from multiple
sources in the solar corona and is highly structured. It is often described
as high-speed, relatively homogeneous, plasma streams from coronal
holes and slow-speed, highly variable, streams whose source regions are
under debate. A key goal of ESA/NASA’s Solar Orbiter mission is to identify
solar wind sources and understand what drives the complexity seen in the
heliosphere. By combining magnetic feld modelling and spectroscopic
techniques with high-resolution observations and measurements, we show
that the solar wind variability detected in situ by Solar Orbiter in March
2022 is driven by spatio-temporal changes in the magnetic connectivity to
multiple sources in the solar atmosphere. The magnetic feld footpoints
connected to the spacecraft moved from the boundaries of a coronal hole
to one active region (12961) and then across to another region (12957). This
is refected in the in situ measurements, which show the transition from fast
to highly Alfvénic then to slow solar wind that is disrupted by the arrival of
a coronal mass ejection. Our results describe solar wind variability at 0.5 au
but are applicable to near-Earth observatories.
Cancer cell metabolism: special Reference to Lactate PathwayAADYARAJPANDEY1
Normal Cell Metabolism:
Cellular respiration describes the series of steps that cells use to break down sugar and other chemicals to get the energy we need to function.
Energy is stored in the bonds of glucose and when glucose is broken down, much of that energy is released.
Cell utilize energy in the form of ATP.
The first step of respiration is called glycolysis. In a series of steps, glycolysis breaks glucose into two smaller molecules - a chemical called pyruvate. A small amount of ATP is formed during this process.
Most healthy cells continue the breakdown in a second process, called the Kreb's cycle. The Kreb's cycle allows cells to “burn” the pyruvates made in glycolysis to get more ATP.
The last step in the breakdown of glucose is called oxidative phosphorylation (Ox-Phos).
It takes place in specialized cell structures called mitochondria. This process produces a large amount of ATP. Importantly, cells need oxygen to complete oxidative phosphorylation.
If a cell completes only glycolysis, only 2 molecules of ATP are made per glucose. However, if the cell completes the entire respiration process (glycolysis - Kreb's - oxidative phosphorylation), about 36 molecules of ATP are created, giving it much more energy to use.
IN CANCER CELL:
Unlike healthy cells that "burn" the entire molecule of sugar to capture a large amount of energy as ATP, cancer cells are wasteful.
Cancer cells only partially break down sugar molecules. They overuse the first step of respiration, glycolysis. They frequently do not complete the second step, oxidative phosphorylation.
This results in only 2 molecules of ATP per each glucose molecule instead of the 36 or so ATPs healthy cells gain. As a result, cancer cells need to use a lot more sugar molecules to get enough energy to survive.
Unlike healthy cells that "burn" the entire molecule of sugar to capture a large amount of energy as ATP, cancer cells are wasteful.
Cancer cells only partially break down sugar molecules. They overuse the first step of respiration, glycolysis. They frequently do not complete the second step, oxidative phosphorylation.
This results in only 2 molecules of ATP per each glucose molecule instead of the 36 or so ATPs healthy cells gain. As a result, cancer cells need to use a lot more sugar molecules to get enough energy to survive.
introduction to WARBERG PHENOMENA:
WARBURG EFFECT Usually, cancer cells are highly glycolytic (glucose addiction) and take up more glucose than do normal cells from outside.
Otto Heinrich Warburg (; 8 October 1883 – 1 August 1970) In 1931 was awarded the Nobel Prize in Physiology for his "discovery of the nature and mode of action of the respiratory enzyme.
WARNBURG EFFECT : cancer cells under aerobic (well-oxygenated) conditions to metabolize glucose to lactate (aerobic glycolysis) is known as the Warburg effect. Warburg made the observation that tumor slices consume glucose and secrete lactate at a higher rate than normal tissues.
Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...Sérgio Sacani
We characterize the earliest galaxy population in the JADES Origins Field (JOF), the deepest
imaging field observed with JWST. We make use of the ancillary Hubble optical images (5 filters
spanning 0.4−0.9µm) and novel JWST images with 14 filters spanning 0.8−5µm, including 7 mediumband filters, and reaching total exposure times of up to 46 hours per filter. We combine all our data
at > 2.3µm to construct an ultradeep image, reaching as deep as ≈ 31.4 AB mag in the stack and
30.3-31.0 AB mag (5σ, r = 0.1” circular aperture) in individual filters. We measure photometric
redshifts and use robust selection criteria to identify a sample of eight galaxy candidates at redshifts
z = 11.5 − 15. These objects show compact half-light radii of R1/2 ∼ 50 − 200pc, stellar masses of
M⋆ ∼ 107−108M⊙, and star-formation rates of SFR ∼ 0.1−1 M⊙ yr−1
. Our search finds no candidates
at 15 < z < 20, placing upper limits at these redshifts. We develop a forward modeling approach to
infer the properties of the evolving luminosity function without binning in redshift or luminosity that
marginalizes over the photometric redshift uncertainty of our candidate galaxies and incorporates the
impact of non-detections. We find a z = 12 luminosity function in good agreement with prior results,
and that the luminosity function normalization and UV luminosity density decline by a factor of ∼ 2.5
from z = 12 to z = 14. We discuss the possible implications of our results in the context of theoretical
models for evolution of the dark matter halo mass function.
Seminar of U.V. Spectroscopy by SAMIR PANDASAMIR PANDA
Spectroscopy is a branch of science dealing the study of interaction of electromagnetic radiation with matter.
Ultraviolet-visible spectroscopy refers to absorption spectroscopy or reflect spectroscopy in the UV-VIS spectral region.
Ultraviolet-visible spectroscopy is an analytical method that can measure the amount of light received by the analyte.
The increased availability of biomedical data, particularly in the public domain, offers the opportunity to better understand human health and to develop effective therapeutics for a wide range of unmet medical needs. However, data scientists remain stymied by the fact that data remain hard to find and to productively reuse because data and their metadata i) are wholly inaccessible, ii) are in non-standard or incompatible representations, iii) do not conform to community standards, and iv) have unclear or highly restricted terms and conditions that preclude legitimate reuse. These limitations require a rethink on data can be made machine and AI-ready - the key motivation behind the FAIR Guiding Principles. Concurrently, while recent efforts have explored the use of deep learning to fuse disparate data into predictive models for a wide range of biomedical applications, these models often fail even when the correct answer is already known, and fail to explain individual predictions in terms that data scientists can appreciate. These limitations suggest that new methods to produce practical artificial intelligence are still needed.
In this talk, I will discuss our work in (1) building an integrative knowledge infrastructure to prepare FAIR and "AI-ready" data and services along with (2) neurosymbolic AI methods to improve the quality of predictions and to generate plausible explanations. Attention is given to standards, platforms, and methods to wrangle knowledge into simple, but effective semantic and latent representations, and to make these available into standards-compliant and discoverable interfaces that can be used in model building, validation, and explanation. Our work, and those of others in the field, creates a baseline for building trustworthy and easy to deploy AI models in biomedicine.
Bio
Dr. Michel Dumontier is the Distinguished Professor of Data Science at Maastricht University, founder and executive director of the Institute of Data Science, and co-founder of the FAIR (Findable, Accessible, Interoperable and Reusable) data principles. His research explores socio-technological approaches for responsible discovery science, which includes collaborative multi-modal knowledge graphs, privacy-preserving distributed data mining, and AI methods for drug discovery and personalized medicine. His work is supported through the Dutch National Research Agenda, the Netherlands Organisation for Scientific Research, Horizon Europe, the European Open Science Cloud, the US National Institutes of Health, and a Marie-Curie Innovative Training Network. He is the editor-in-chief for the journal Data Science and is internationally recognized for his contributions in bioinformatics, biomedical informatics, and semantic technologies including ontologies and linked data.
This pdf is about the Schizophrenia.
For more details visit on YouTube; @SELF-EXPLANATORY;
https://www.youtube.com/channel/UCAiarMZDNhe1A3Rnpr_WkzA/videos
Thanks...!
Nutraceutical market, scope and growth: Herbal drug technologyLokesh Patil
As consumer awareness of health and wellness rises, the nutraceutical market—which includes goods like functional meals, drinks, and dietary supplements that provide health advantages beyond basic nutrition—is growing significantly. As healthcare expenses rise, the population ages, and people want natural and preventative health solutions more and more, this industry is increasing quickly. Further driving market expansion are product formulation innovations and the use of cutting-edge technology for customized nutrition. With its worldwide reach, the nutraceutical industry is expected to keep growing and provide significant chances for research and investment in a number of categories, including vitamins, minerals, probiotics, and herbal supplements.
Introduction:
RNA interference (RNAi) or Post-Transcriptional Gene Silencing (PTGS) is an important biological process for modulating eukaryotic gene expression.
It is highly conserved process of posttranscriptional gene silencing by which double stranded RNA (dsRNA) causes sequence-specific degradation of mRNA sequences.
dsRNA-induced gene silencing (RNAi) is reported in a wide range of eukaryotes ranging from worms, insects, mammals and plants.
This process mediates resistance to both endogenous parasitic and exogenous pathogenic nucleic acids, and regulates the expression of protein-coding genes.
What are small ncRNAs?
micro RNA (miRNA)
short interfering RNA (siRNA)
Properties of small non-coding RNA:
Involved in silencing mRNA transcripts.
Called “small” because they are usually only about 21-24 nucleotides long.
Synthesized by first cutting up longer precursor sequences (like the 61nt one that Lee discovered).
Silence an mRNA by base pairing with some sequence on the mRNA.
Discovery of siRNA?
The first small RNA:
In 1993 Rosalind Lee (Victor Ambros lab) was studying a non- coding gene in C. elegans, lin-4, that was involved in silencing of another gene, lin-14, at the appropriate time in the
development of the worm C. elegans.
Two small transcripts of lin-4 (22nt and 61nt) were found to be complementary to a sequence in the 3' UTR of lin-14.
Because lin-4 encoded no protein, she deduced that it must be these transcripts that are causing the silencing by RNA-RNA interactions.
Types of RNAi ( non coding RNA)
MiRNA
Length (23-25 nt)
Trans acting
Binds with target MRNA in mismatch
Translation inhibition
Si RNA
Length 21 nt.
Cis acting
Bind with target Mrna in perfect complementary sequence
Piwi-RNA
Length ; 25 to 36 nt.
Expressed in Germ Cells
Regulates trnasposomes activity
MECHANISM OF RNAI:
First the double-stranded RNA teams up with a protein complex named Dicer, which cuts the long RNA into short pieces.
Then another protein complex called RISC (RNA-induced silencing complex) discards one of the two RNA strands.
The RISC-docked, single-stranded RNA then pairs with the homologous mRNA and destroys it.
THE RISC COMPLEX:
RISC is large(>500kD) RNA multi- protein Binding complex which triggers MRNA degradation in response to MRNA
Unwinding of double stranded Si RNA by ATP independent Helicase
Active component of RISC is Ago proteins( ENDONUCLEASE) which cleave target MRNA.
DICER: endonuclease (RNase Family III)
Argonaute: Central Component of the RNA-Induced Silencing Complex (RISC)
One strand of the dsRNA produced by Dicer is retained in the RISC complex in association with Argonaute
ARGONAUTE PROTEIN :
1.PAZ(PIWI/Argonaute/ Zwille)- Recognition of target MRNA
2.PIWI (p-element induced wimpy Testis)- breaks Phosphodiester bond of mRNA.)RNAse H activity.
MiRNA:
The Double-stranded RNAs are naturally produced in eukaryotic cells during development, and they have a key role in regulating gene expression .
8. www.era7bioinformatics.com
National Microbiome Initiative definition:
“Microbiomes are the communities of
microorganisms that live on or in people,
plants, soil, oceans, and the atmosphere.
Microbiomes maintain healthy function of
these diverse ecosystems, influencing
human health, climate change, food
security, and other factors”
18. www.era7bioinformatics.com
The Microbiome has got a great interest
recently:
• Humans: in different parts of the body
• Environmental: soils, water, oceans ….
• Industrial: farms, food …..
• Places: Hospitals, tools, phones, trains…
25. www.era7bioinformatics.com
• Obesity
• Type 1 Diabetes
• Type 2 Diabetes
• Colon cancer
• Asthma
• Atherosclerosis
• Autism
• Autoimmunity
• Cardiovascular Disease
• Crohn
• Cystic Fibrosis
Not exhaustive list of health conditions related with Gut
Microbiome:
• Skin disorders
• Inflammation
• Fe deficiency
• Multiple Sclerosis
• Obesidad
• Rheumatoid Arthritis
• Parkinson
• Sarcoidosis
• Stroke
• AIDS
26. www.era7bioinformatics.com
The Microbiome shapes The Immune System
Some examples:
• Mice do not have Blood-Brain barrier when their gut is
sterile.
• In Cancer Immunotherapy in mice, results depend on
the Microbiome composition
• In mice, Stroke recovery depends on The Microbiome
composition as demonstrated after antibiotics treatment
27. www.era7bioinformatics.com
The Human Microbiome is closely related
with The Immune System and, thus, in Era7
Bioinformatics we can also do:
• HLA typing
• TCR repertoire
• BCR repertoire
28. www.era7bioinformatics.com
We have several approaches to
analyse The Microbiome
• 16S and 18S
• Shotgun metagenomics
• Other targeted sequencing
29. www.era7bioinformatics.com
16S and 18S taxonomic profiling
With 16S sequencing you get info from
bacteria and archaea. Is much more cheaper
than Shotgun approach and very good results
can be obtained.
31. www.era7bioinformatics.com
16S and 18S taxonomic profiling
illumina approach:
You get information from 16S rRNA gene v3
and v4 variable regions sequencing an
amplicon
32. www.era7bioinformatics.com
16S and 18S taxonomic profiling
PacBio approach:
You get information from full length 16S sRNA
gene sequencing an amplicon containing all
the 9 variable regions:
33. www.era7bioinformatics.com
16S and 18S taxonomic profiling
In any approach, illumina or PacBio,
our MG7 pipeline and DB7 reference
database get the best results that
each technology can provide
34. www.era7bioinformatics.com
Shotgun approach:
All the DNA present in the metagenomics
sample is sequenced and analysed:
You get information from all kinds of
organisms but sequencing and analysis cost
is higher
36. www.era7bioinformatics.com
There are also many things influencing the
Microbiome:
• Antibiotics
• Diet
• Genome
• Immune System
• Exercise
• Pets
• Infections
• Age
• Jet-Lag
• ………..
37. www.era7bioinformatics.com
Era7 has a very specialised
and multidisciplinary team
• Mathematicians
• Software engineers
• Biochemists
• Microbiologists
• Medical Doctors
39. www.era7bioinformatics.com
Microbiome Biomarkers will be
applied very soon to Clinics
Era7 Bioinformatics is developing EHR integration
and new rich interactive visualisations for
clinicians in the context of our R&D project
“Cardiobiome”
41. www.era7bioinformatics.com
Cardiobiome project:
• Cloud Microbiome analysis integrated
with Electronic Health Record (EHR)
• New rich interactive visualisation tools
designed for clinicians
• Microbiome analysis of Acute Myocardial
Infarction as a proof of concept
43. www.era7bioinformatics.com
• Era7 is present in The United States in
Cambridge Massachusetts
• Era7 has its own specially designed methods for
Microbiome analysis: MG7 and DB7
• Era7 team is very experienced in Genomics Big
Data analysis
• Era7 team is based in knowledge and in research
45. www.era7bioinformatics.com
Era7 has launched recently a
portal with Microbiome related
information , from references to
news and simple tools:
www.themicrobiome.com
48. MG7 Bioinformatics analysis for 16S
MG7 is a complete analysis tool developed by Era7
Bioinformatics oriented to provide taxonomic
assignment results for big sets of sequences.
MG7 pipelines of analysis are continuously being
updated with the newest approaches.
www.era7bioinformatics.com
49. Our rRNA reference database DB7
We have built our reference database DB7 of 16S and
18S sequences based on the complete RNAcentral
release 5 . RNAcentral is a general database for all the
types of non coding RNA maintained by RNAcentral
Consortium
MG7 Bioinformatics analysis for 16S
www.era7bioinformatics.com
50. Our taxonomic assignment algorithm is
exhaustive
We compare each read against all the sequences of
our DB7 database. The taxonomic assignment for each
read is based on the results of BLASTN of each read
against our DB7 database.
MG7 Bioinformatics analysis for 16S
www.era7bioinformatics.com
51. Our algorithm for taxonomic assignment provides
results for two different assignment approaches:
• Best Blast Hit (BBH)
• Lowest Common Ancestor (LCA)
MG7 Bioinformatics analysis for 16S
www.era7bioinformatics.com
52. MG7 provides a rich set of deliverables with 4 different
types of abundance values for each of the 2
approaches (BBH and LCA) to evaluate the frequencies
of bacterial and archaeal organisms:
• direct values and cumulative abundance values
• absolute counts and abundance percentages
DELIVERABLES of MG7 Bioinformatics
analysis for 16S
www.era7bioinformatics.com
53. Best BLAST Hit (BBH):
• Direct Assignment, Absolute Values
• Direct Assignment, Percentage Values
• Cumulative Assignment, Absolute Values
• Cumulative Assignment, Percentage Values
Lowest Common Ancestor Algorithm (LCA):
• Direct Assignment, Absolute Values
• Direct Assignment, Percentage Values
• Cumulative Assignment, Absolute Values
• Cumulative Assignment, Percentage Values
www.era7bioinformatics.com
DELIVERABLES of MG7 Bioinformatics
analysis for 16S
54. MG7 provides a rich set of deliverables including tables
per sample, per groups of samples, global, per ranks:
• Abundance tables per sample
• All the ranks in a complete table
• Abundances for each rank
• Abundance tables per each defined group of samples
• Abundance tables for all the samples together
www.era7bioinformatics.com
DELIVERABLES of MG7 Bioinformatics
analysis for 16S
55. MG7 provides a rich set of deliverables including
Analysis of diversity indexes
The Shannon-Wiener and Simpson’s diversity
indexes are calculated for each sample.
www.era7bioinformatics.com
DELIVERABLES of MG7 Bioinformatics
analysis for 16S
56. Comparison of groups of samples
We provide statistical analysis for the study of
differences between groups of samples. We use for it
open tools based on R software from CRAN (The
Comprehensive R Archive Network). In each case we
apply the most appropriate approaches.
www.era7bioinformatics.com
DELIVERABLES of MG7 Bioinformatics
analysis for 16S
57. Some types of statistical analysis provided for the
comparison of groups of samples:
• Univariate statistics (fold change analysis, t-tests, volcano plots, one-way
ANOVA, correlation analysis)
• Multivariate statistics (principal component analysis , partial least
squares discriminant analysis)
• Clustering (dendrograms, heatmaps, K-means clustering, self organizing
feature maps)
• Supervised classification (random forests, support vector machine)
www.era7bioinformatics.com
DELIVERABLES of MG7 Bioinformatics
analysis for 16S
58. Charts and Reports that MG7 provides
Different types of charts with the possibility of providing
interactive visualizations (See our research project
BIOGRAPHIKA about interactive visualizations)
Complete results in compliant formats
Technical reports ready to scientific publication
www.era7bioinformatics.com
DELIVERABLES of MG7 Bioinformatics
analysis for 16S
59. MG7 workflow for 16S
• Our Reference database DB7
• Exhaustive taxonomic assignment
for each read
• Two different taxonomic
assignment approaches, Best Blast
Hit (BBH) and Lowest Common
Ancestor (LCA)
• A complete set of deliverables
www.era7bioinformatics.com
61. Full-length 16S taxonomic profiling with PacBio
and Era7 Bioinformatics MG7
• 100% of the hypervariable regions
• Obtaining 16S full gene sequences
• More specific taxonomic assignments
www.era7bioinformatics.com
62. www.era7bioinformatics.com
Our service of
Taxonomic Profiling
with PacBio:
Primer position in
16S gene. Includes
v1 to v9 regions
Taken from
www.themicrobiome.com
65. www.era7bioinformatics.com
Regardless your platform of
preference…
We can also provide further tailored
interpretation services based in our
Bio4j bioinformatics platform
66. Bio4j is a bioinformatics graph based DB
including most data available in:
- UniProt (SwissProt + Trembl)
- UniRef (50,90,100)
- Gene Ontology (GO)
- RefSeq
- NCBI taxonomy
- Enzyme DB
Big Data:
- 2.000.000.000 relationships
- 400.000.000 nodes
- 1.000.000.000 properties
www.era7bioinformatics.com
68. www.era7bioinformatics.com
Era7 Bioinformatics can also do data
integration with other -omics results
and design specialised databases for
your results and tailored visualisation
tools
69. www.era7bioinformatics.com
In summary, with Era7 Bioinformatics
you will have a very specialised team
using a wonderful pipeline and the
possibility of obtaining tailored
approaches, databases and and data
integration.